Compare TY & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TY | SDGR |
|---|---|---|
| Founded | 1929 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.5B |
| IPO Year | 1994 | 2020 |
| Metric | TY | SDGR |
|---|---|---|
| Price | $34.62 | $25.46 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $23.86 |
| AVG Volume (30 Days) | 32.9K | ★ 3.0M |
| Earning Date | 01-01-0001 | 11-04-2026 |
| Dividend Yield | ★ 3.36% | N/A |
| EPS Growth | N/A | ★ 45.14 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $255,869,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.09 |
| P/E Ratio | $7.50 | ★ N/A |
| Revenue Growth | N/A | ★ 23.29 |
| 52 Week Low | $30.53 | $10.95 |
| 52 Week High | $36.55 | $33.78 |
| Indicator | TY | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 45.06 | 47.58 |
| Support Level | $34.16 | $11.27 |
| Resistance Level | $35.06 | $31.59 |
| Average True Range (ATR) | 0.46 | 1.97 |
| MACD | 0.05 | -0.90 |
| Stochastic Oscillator | 37.20 | 16.79 |
Tri-Continental Corp is a closed-end management investment company. It invests to produce future growth of both capital and income while providing reasonable current income. The fund is divided into two equal segments namely, the equity segment uses quantitative models to select individual stocks whereas the Flexible capital income segment invests across a company's investable capital structure, including stocks, bonds, and convertible securities. The Fund invests in a range of sectors, which include consumer discretionary, consumer staples, energy, financials, healthcare, industrials, information technology, industrials, materials, real estate, telecommunication services, utilities, aerospace and defense, banking, chemicals, and others.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.